Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 2
1963 3
1964 1
1965 1
1966 1
1980 3
1981 1
1982 2
1983 4
1984 2
1985 2
1986 6
1987 7
1988 8
1989 3
1990 12
1991 4
1992 8
1993 17
1994 27
1995 26
1996 34
1997 30
1998 27
1999 30
2000 40
2001 35
2002 60
2003 87
2004 100
2005 155
2006 164
2007 181
2008 241
2009 282
2010 356
2011 399
2012 525
2013 623
2014 713
2015 841
2016 917
2017 1071
2018 1292
2019 1517
2020 1622
2021 1911
2022 2267
2023 255
Text availability
Article attribute
Article type
Publication date

Search Results

14,158 results
Results by year
Filters applied: . Clear all
Page 1
Viral Coinfections.
Du Y, Wang C, Zhang Y. Du Y, et al. Viruses. 2022 Nov 26;14(12):2645. doi: 10.3390/v14122645. Viruses. 2022. PMID: 36560647 Free PMC article. Review.
Retraction Notice to: A Novel Mechanism of Doxorubicin Resistance and Tumorigenesis Mediated by MicroRNA-501-5p-Suppressed BLID.
Xu YC, Liu X, Li M, Li Y, Li CY, Lu Y, Sanches J, Wang L, Du Y, Mao LM, Zuo SB, Liu HT, Shen J, Wang B, Hou L, Li LH, Tang JW, Ju JF, Guan HW, Song B. Xu YC, et al. Among authors: du y. Mol Ther Nucleic Acids. 2022 Nov 9;30:378. doi: 10.1016/j.omtn.2022.11.002. eCollection 2022 Dec 13. Mol Ther Nucleic Acids. 2022. PMID: 36420222 Free PMC article.
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial.
Urva S, Coskun T, Loh MT, Du Y, Thomas MK, Gurbuz S, Haupt A, Benson CT, Hernandez-Illas M, D'Alessio DA, Milicevic Z. Urva S, et al. Among authors: du y. Lancet. 2022 Nov 26;400(10366):1869-1881. doi: 10.1016/S0140-6736(22)02033-5. Epub 2022 Oct 27. Lancet. 2022. PMID: 36354040 Clinical Trial.
PROTACs in gastrointestinal cancers.
Chen Y, Yang Q, Xu J, Tang L, Zhang Y, Du F, Zhao Y, Wu X, Li M, Shen J, Ding R, Cao H, Li W, Li X, Chen M, Wu Z, Cho CH, Du Y, Wen Q, Xiao Z. Chen Y, et al. Among authors: du y. Mol Ther Oncolytics. 2022 Nov 3;27:204-223. doi: 10.1016/j.omto.2022.10.012. eCollection 2022 Dec 15. Mol Ther Oncolytics. 2022. PMID: 36420306 Free PMC article. Review.
Targeting Tumor-Associated Macrophages for Imaging.
Hu J, Xu X, Du Y. Hu J, et al. Among authors: du y. Pharmaceutics. 2022 Dec 31;15(1):144. doi: 10.3390/pharmaceutics15010144. Pharmaceutics. 2022. PMID: 36678773 Free PMC article. Review.
The Epidemiology, Diagnosis and Prognosis of Long-COVID.
Du Y, Zhang J, Wu LJ, Zhang Q, Wang YX. Du Y, et al. Biomed Environ Sci. 2022 Dec 20;35(12):1133-1139. doi: 10.3967/bes2022.143. Biomed Environ Sci. 2022. PMID: 36597293 Free article. Review. No abstract available.
14,158 results
You have reached the last available page of results. Please see the User Guide for more information.